Donglin Liu

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Weidong Ma · 2 shared papers, 2023 · strength 0.40
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
2. Huaqiang Ouyang · 2 shared papers, 2023 · strength 0.40
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
3. Anna Sandström Gerdtsson · 2 shared papers, 2023 · strength 0.40
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
4. Zhanyu Pan · 1 shared paper, 2023 · strength 0.22
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
5. Zhuchen Yan · 1 shared paper, 2023 · strength 0.18
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
6. Ping Chen · 1 shared paper, 2023 · strength 0.18
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
7. Tongguo Si · 1 shared paper, 2023 · strength 0.18
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
8. David V. Gold · 2 shared papers, 2013–2015 · strength 0.12
   • Paper Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for panc… DOI 10.18632/oncotarget.2760↗
   • Paper Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic duc… DOI 10.1186/1476-4598-12-143↗
9. David M. Goldenberg · 2 shared papers, 2013–2015 · strength 0.12
   • Paper Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for panc… DOI 10.18632/oncotarget.2760↗
   • Paper Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic duc… DOI 10.1186/1476-4598-12-143↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.